Results 131 to 140 of about 16,632 (221)
Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension
Movement Disorders Clinical Practice, 2017 AbstractBackgroundOrthostatic hypotension (OH) is a sustained fall in blood pressure on standing that can cause symptoms of organ hypoperfusion. OH is associated with increased morbidity and mortality and leads to a significant number of hospital admissions, particularly in the elderly (233 per 100,000 patients >75 years of age in the United States).
Jose‐Alberto Palma, Horacio Kaufmann
openaire +3 more sources
The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome. [PDF]
, 2014 OBJECTIVE To evaluate the efficacy and safety of duloxetine hydrochloride in the treatment of patients affected by chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
Di Stasi, SM +4 more
core +1 more source
Frontiers in Neurology, 2019 In its early stages multiple system atrophy (MSA), a neurodegenerative movement disorder, can be difficult to differentiate from idiopathic Parkinson's disease (PD), and emphasis has been put on identifying premotor symptoms to allow for its early ...
Tobias Warnecke +9 more
doaj +1 more source
Risk of Orthostatic Intolerance During Re-Exposure to Gravity [PDF]
Post-spaceflight orthostatic intolerance remains a significant concern to NASA. In Space Shuttle missions, astronauts wore anti-gravity suits and liquid cooling garments to protect against orthostatic intolerance during re-entry and landing, but in ...
Arzeno, Natalia M. +7 more
core +1 more source
신경인성 기립성저혈압 치료에 미도드린, 피리도스티그민과 아토목세틴의 효과 비교 연구 [PDF]
, 2019 학위논문 (박사)-- 서울대학교 대학원 : 의과대학 협동과정 임상약리학전공, 2019. 2. 이상건.Midodrine is the mainstay treatment, and pyridostigmine and atomoxetin are common drugs used for patients with orthostatic hypotension (OH).
변정익
core
Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology [PDF]
Background and objective Non-motor symptoms frequently develop throughout the disease course of Parkinson’s disease (PD), and pose affected individuals at risk of complications, more rapid disease progression and poorer quality of life.
Becktepe, Jos +11 more
core +1 more source
Neuropsychiatric Disease and Treatment, 2021 Yasar Torres-Yaghi, Amelia Carwin, Jacob Carolan, Steven Nakano, Fahd Amjad, Fernando Pagan Department of Neurology, National Parkinson’s Foundation Center for Excellence, Translational Neurotherapeutics Program, Movement Disorders Program, MedStar ...
Torres-Yaghi Y +5 more
doaj
Alzheimer’s Research & TherapyBackground In dementia with Lewy bodies (DLB), autonomic and neurosensory disorders can precede neurocognitive symptoms by several years. Improving knowledge of these symptoms is essential to avoid associated complications and could reveal potential ...
Morgane Linard +9 more
doaj +1 more source
Neurogenic orthostatic hypotension: the very basics [PDF]
Clinical Autonomic Research, 2017 Horacio Kaufmann, Jose-Alberto Palma
openaire +2 more sources
Aerospace medicine and biology: A continuing bibliography with indexes, supplement 130, July 1974 [PDF]
This special bibliography lists 291 reports, articles, and other documents introduced into the NASA scientific and technical information system in June ...
core +1 more source